Core Points - Rosen Law Firm is reminding investors who purchased Marex Group plc securities between May 16, 2024, and August 5, 2025, of the December 8, 2025, lead plaintiff deadline for a class action lawsuit [1] - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] Company Details - The lawsuit alleges that Marex made materially false and misleading statements, including selling over-the-counter financial instruments to itself and inconsistencies in financial statements between subsidiaries [4] - As a result of these issues, Marex's financial statements were deemed unreliable, and positive statements about the company's business were misleading [4] Legal Representation - Investors are encouraged to select qualified legal counsel with a successful track record in securities class actions [3] - Rosen Law Firm has achieved significant settlements in the past, including over $438 million for investors in 2019 and has been ranked highly for its performance in securities class action settlements [3]

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Marex Group plc due to allegations of securities law violations, with a deadline for investors to seek lead plaintiff status in a federal class action by December 8, 2025 [2][5]. Group 1: Allegations Against Marex - The complaint alleges that Marex and its executives made false or misleading statements and failed to disclose critical information, including the sale of over-the-counter financial instruments to itself and inconsistencies in financial statements [5]. - Specific allegations include a multi-year accounting scheme involving off-balance-sheet entities, fictitious transactions, and misleading disclosures to hide losses and inflate profits, with examples such as a $17 million fabricated receivable and nearly $1 billion in concealed derivatives exposure [6]. - Following the release of a damaging report by NINGI Research, Marex's stock experienced a significant decline of 6.2%, closing at $35.31 [7]. Group 2: Legal Proceedings and Investor Actions - Investors who purchased Marex securities between May 16, 2024, and August 5, 2025, are encouraged to contact Faruqi & Faruqi to discuss their legal rights and options [1]. - The role of lead plaintiff in the class action is designated to the investor with the largest financial interest, who will oversee the litigation on behalf of the class [8]. - Faruqi & Faruqi is also seeking information from whistleblowers, former employees, and shareholders regarding Marex's conduct [9].

Core Viewpoint - The Rosen Law Firm is urging investors of Marex Group plc to secure legal counsel before the December 8, 2025 deadline for a securities class action lawsuit related to misleading financial statements and practices during the class period from May 16, 2024, to August 5, 2025 [1][5]. Group 1: Legal Action Details - Investors who purchased Marex securities during the specified class period may be eligible for compensation without incurring out-of-pocket fees through a contingency fee arrangement [2]. - To participate in the class action, investors must act before the December 8, 2025 deadline to be considered for lead plaintiff status, which involves directing the litigation on behalf of other class members [3][6]. - The lawsuit alleges that Marex made materially false statements and failed to disclose critical information regarding its financial practices, leading to investor damages when the truth was revealed [5]. Group 2: Rosen Law Firm's Credentials - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting its own success in achieving significant settlements for investors [4]. - The firm has been recognized for its performance in securities class action settlements, including being ranked No. 1 by ISS Securities Class Action Services in 2017 and securing over $438 million for investors in 2019 [4].

Core Viewpoint - A class action securities lawsuit has been filed against Marex Group plc, alleging securities fraud that affected shareholders between May 16, 2024, and August 5, 2025 [2]. Group 1: Lawsuit Details - The lawsuit seeks to recover losses for shareholders who were adversely affected by alleged securities fraud during the specified period [2]. - The complaint claims that defendants made false statements and concealed information regarding the improper inflation of cash flow, revenues, assets, and profits in the Market Making segment through off-book intercompany transactions [3]. - As a result of these actions, the positive statements made by the defendants about the company's business and prospects were materially false and misleading [3]. Group 2: Next Steps for Affected Shareholders - Shareholders who suffered losses in Marex Group plc stock during the relevant timeframe are encouraged to learn about their rights to seek recovery, with no cost or obligation to participate [4]. Group 3: Legal Representation - Levi & Korsinsky LLP is highlighted as a nationally-recognized securities litigation firm with a strong track record of securing significant recoveries for shareholders [5]. - The firm has over 20 years of experience in securities litigation and has been consistently ranked among the top securities litigation firms in the United States [5].

Core Viewpoint - Rosen Law Firm is encouraging investors of Marex Group plc to secure legal counsel before the December 8, 2025 deadline for a securities class action related to misleading financial statements and practices [1][5]. Group 1: Class Action Details - The class period for the securities class action is from May 16, 2024, to August 5, 2025 [1]. - Investors who purchased Marex securities during this period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To participate in the class action, investors must act before the lead plaintiff deadline of December 8, 2025 [3]. Group 2: Allegations Against Marex - The lawsuit alleges that Marex made materially false and misleading statements, including selling over-the-counter financial instruments to itself and inconsistencies in financial statements among subsidiaries [5]. - It is claimed that Marex's financial statements could not be relied upon due to these issues, leading to misleading positive statements about the company's business and operations [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company at the time and being ranked No. 1 for securities class action settlements in 2017 [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4]. - Many attorneys at Rosen Law Firm have received recognition from Lawdragon and Super Lawyers, emphasizing the firm's expertise in this area [4].

NEW YORK, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Marex Group plc ("Marex Group plc" or the "Company") (NASDAQ: MRX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Marex Group plc investors who were adversely affected by alleged securities fraud between May 16, 2024 and August 5, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/marex-group-plc-l ...

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Marex Group plc and is encouraging investors who suffered losses to discuss their legal options before the December 8, 2025 deadline for seeking lead plaintiff status in a federal securities class action [1] Company Summary - Marex Group plc (NASDAQ: MRX) is currently facing scrutiny due to potential securities litigation [1] - The investigation is focused on the period between May 16, 2024, and August 5, 2025, during which investors may have incurred losses [1] Legal Context - A federal securities class action has been filed against Marex, with a deadline of December 8, 2025, for investors to seek the role of lead plaintiff [1] - Faruqi & Faruqi, LLP is a national securities law firm leading the investigation and outreach to affected investors [1]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of Marex Group plc during the specified Class Period of the upcoming lead plaintiff deadline on December 8, 2025, and the potential for compensation without out-of-pocket costs [1][2]. Group 1: Class Action Details - The class action pertains to securities purchased between May 16, 2024, and August 5, 2025, and investors may be entitled to compensation through a contingency fee arrangement [1]. - Investors wishing to serve as lead plaintiff must file a motion with the Court by December 8, 2025, to represent other class members [2]. Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company at the time and being ranked No. 1 for securities class action settlements in 2017 [3]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [3]. Group 3: Case Allegations - The lawsuit alleges that Marex made materially false and misleading statements, including selling over-the-counter financial instruments to itself and inconsistencies in financial statements [4]. - As a result of these actions, Marex's financial statements were deemed unreliable, leading to misleading positive statements about its business and operations [4].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Marex Group plc due to allegations of securities law violations, with a deadline for investors to seek lead plaintiff status in a class action lawsuit by December 8, 2025 [2][5]. Group 1: Allegations Against Marex - The complaint alleges that Marex and its executives made false and misleading statements and failed to disclose critical information, including the sale of over-the-counter financial instruments to itself and inconsistencies in financial statements [5]. - Specific allegations include a multi-year accounting scheme involving off-balance-sheet entities, fictitious transactions, and misleading disclosures to hide losses and inflate profits, with examples such as a $17 million fabricated receivable and nearly $1 billion in concealed derivatives exposure [6]. Group 2: Market Reaction - Following the release of a report by NINGI Research on August 5, 2025, Marex's stock experienced a significant decline of 6.2%, closing at $35.31 on heavy trading volume [7]. Group 3: Legal Proceedings - The role of the lead plaintiff in the class action is designated for the investor with the largest financial interest who is also typical of class members, with the option for any member to move the court to serve as lead plaintiff [8]. - Faruqi & Faruqi encourages individuals with information regarding Marex's conduct to come forward, including whistleblowers and former employees [9].

Core Viewpoint - Marex Group PLC is facing a class action lawsuit for allegedly misleading investors about its revenue projections and inflating its financial metrics through improper accounting practices [1][2]. Group 1: Company Overview - Marex Group PLC is a U.K.-based diversified global financial services platform [1]. Group 2: Legal Allegations - The lawsuit claims that Marex Group failed to disclose that it improperly inflated its cash flow, revenues, assets, and profits of its Market Making segment through off-book intercompany transactions [2]. - As a result of these alleged actions, class members have reportedly suffered significant losses and damages [2]. Group 3: Class Action Participation - Shareholders may be eligible to participate in the class action against Marex Group PLC, with a deadline to submit papers to serve as lead plaintiff by December 8, 2025 [3]. - Participation in the case is not required to be eligible for recovery, allowing shareholders to remain absent class members if they choose [3]. Group 4: Legal Representation - Robbins LLP is leading the class action, operating on a contingency fee basis, meaning shareholders incur no fees or expenses unless the case is successful [4].